382 filings
Page 7 of 20
8-K
98g5388hsubd s9qxg1u
6 Nov 14
Spectrum Pharmaceuticals Reports Strong Product Sales for the Third Quarter 2014; Sales of $47.9 Million up 15.6% Over Last Year
12:00am
8-K
wxyayjekbxmdtg m5x
7 Aug 14
Launches Fifth Product and Moves Closer to a Decision on a Potential Blockbuster
12:00am
8-K
liig5b w4
3 Jul 14
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
12:00am
8-K
oerso4x
27 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zvq bkghtzal4w
26 Jun 14
First Amendment to License Agreement
12:00am
8-K
pvu1jh wq
12 May 14
Departure of Directors or Certain Officers
12:00am
8-K
iysp7d 7i0hwgf6b
8 May 14
Spectrum Pharmaceuticals Reports Financial Results for First Quarter 2014
12:00am
8-K
is0yi0
17 Apr 14
Departure of Directors or Certain Officers
12:00am
8-K
vli4e8j
11 Apr 14
Entry into a Material Definitive Agreement
12:00am
8-K
mj18s27wqw
10 Apr 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
fisjk z2pdrv8s9p
31 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
buc2x13m5w
21 Mar 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
htz1sm8clpbe6 ir9
6 Mar 14
Spectrum Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
12:00am
8-K
m0kli
6 Feb 14
Spectrum Pharmaceuticals Announces FDA’s Acceptance of NDA Filing for Beleodaq™ (belinostat) for Injection, a novel pan-HDAC inhibitor
12:00am
8-K
vribhvmd
13 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
ulqrq43pw
23 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
qws1cheyke8 xp6enl
19 Dec 13
Financial Statements and Exhibits
12:00am
8-K
enabtbnd
6 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K/A
wlkcins1w277a
18 Nov 13
Amendment to License and Collaboration Agreement
12:00am
8-K
4l3gtrt5
12 Nov 13
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am